Literature DB >> 21908510

Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines.

D E Peterson1, R-J Bensadoun, F Roila.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21908510      PMCID： PMC3662500          DOI： 10.1093/annonc/mdr391

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  35 in total

1.  Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma.

Authors:  G Calais; M Alfonsi; E Bardet; C Sire; T Germain; P Bergerot; B Rhein; J Tortochaux; P Oudinot; P Bertrand
Journal:  J Natl Cancer Inst       Date:  1999-12-15       Impact factor: 13.506

2.  Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: a comparison with sugar permeability tests.

Authors:  Ludy C H W Lutgens; Nicole M A Blijlevens; Nicolaas E P Deutz; J Peter Donnelly; Philippe Lambin; Ben E de Pauw
Journal:  Cancer       Date:  2005-01-01       Impact factor: 6.860

3.  French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).

Authors:  René-Jean Bensadoun; Karen Bénézery; Olivier Dassonville; Nicolas Magné; Gilles Poissonnet; Alain Ramaïoli; Claire Lemanski; Sylvain Bourdin; Jacques Tortochaux; Frédéric Peyrade; Pierre-Yves Marcy; Emmanuel Chamorey; Jacques Vallicioni; Hang Seng; Claude Alzieu; Bernard Géry; Pierre Chauvel; Maurice Schneider; José Santini; François Demard; Gilles Calais
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-01-10       Impact factor: 7.038

4.  Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study.

Authors:  Quynh-Thu Le; Harold E Kim; Charles J Schneider; Györgyi Muraközy; Krzysztof Skladowski; Sabine Reinisch; Yuhchyau Chen; Michael Hickey; May Mo; Mon-Gy Chen; Dietmar Berger; Richard Lizambri; Michael Henke
Journal:  J Clin Oncol       Date:  2011-06-13       Impact factor: 44.544

5.  Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma.

Authors:  Fabrice Denis; Pascal Garaud; Etienne Bardet; Marc Alfonsi; Christian Sire; Thierry Germain; Philippe Bergerot; Beatrix Rhein; Jacques Tortochaux; Gilles Calais
Journal:  J Clin Oncol       Date:  2003-12-02       Impact factor: 44.544

Review 6.  Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients.

Authors:  Stephen T Sonis; Linda S Elting; Dorothy Keefe; Douglas E Peterson; Mark Schubert; Martin Hauer-Jensen; B Nebiyou Bekele; Judith Raber-Durlacher; J Peter Donnelly; Edward B Rubenstein
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

7.  Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis.

Authors:  Edward B Rubenstein; Douglas E Peterson; Mark Schubert; Dorothy Keefe; Deborah McGuire; Joel Epstein; Linda S Elting; Philip C Fox; Catherine Cooksley; Stephen T Sonis
Journal:  Cancer       Date:  2004-05-01       Impact factor: 6.860

8.  Clinical pharmacokinetic study of 5-FU in continuous 5-day infusions for head and neck cancer.

Authors:  A Thyss; G Milano; N Renée; J Vallicioni; M Schneider; F Demard
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

9.  Phase II trial of cisplatin, fluorouracil, and pure folinic acid for locally advanced head and neck cancer: a pharmacokinetic and clinical survey.

Authors:  M Schneider; M C Etienne; G Milano; A Thyss; J Otto; O Dassonville; H Mobayen; L Saudes; T Guillot; F Demard
Journal:  J Clin Oncol       Date:  1995-07       Impact factor: 44.544

10.  Clinical and pharmacokinetic risk factors for high-dose methotrexate-induced toxicity in children with acute lymphoblastic leukemia--a logistic regression analysis.

Authors:  C Rask; F Albertioni; S M Bentzen; H Schroeder; C Peterson
Journal:  Acta Oncol       Date:  1998       Impact factor: 4.089
View more
  54 in total

1.  New roles of serotonin and tachykinins in intestinal mucositis?

Authors:  Brid Callaghan; John B Furness
Journal:  Dig Dis Sci       Date:  2013-12       Impact factor: 3.199

2.  Potential of Omega-3 Polyunsaturated Fatty Acids in Managing Chemotherapy- or Radiotherapy-Related Intestinal Microbial Dysbiosis.

Authors:  Yue Zhang; Boyan Zhang; Lihua Dong; Pengyu Chang
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

3.  Lack of a significant pharmacokinetic interaction between maraviroc and tacrolimus in allogeneic HSCT recipients.

Authors:  Alex Ganetsky; Todd A Miano; Mitchell E Hughes; Robert H Vonderheide; David L Porter; Ran Reshef
Journal:  J Antimicrob Chemother       Date:  2015-04-16       Impact factor: 5.790

4.  Use of Curcumin Mouthrinse in Radio-Chemotherapy Induced Oral Mucositis Patients: A Pilot Study.

Authors:  Karthikeya Patil; Mahima V Guledgud; P K Kulkarni; Deepika Keshari; Srishti Tayal
Journal:  J Clin Diagn Res       Date:  2015-08-01

5.  Fentanyl pectin nasal spray for painful mucositis in head and neck cancers during intensity-modulated radiation therapy with or without chemotherapy.

Authors:  R Mazzola; F Ricchetti; A Fiorentino; N Giaj-Levra; S Fersino; U Tebano; S Albanese; S Gori; F Alongi
Journal:  Clin Transl Oncol       Date:  2016-11-16       Impact factor: 3.405

Review 6.  Adverse event management of oral mucositis in patients with breast cancer.

Authors:  Sabine Seiler; Jens Kosse; Sibylle Loibl; Christian Jackisch
Journal:  Breast Care (Basel)       Date:  2014-04       Impact factor: 2.860

7.  A Randomized Placebo- Controlled Double Blind Clinical Trial of Quercetin in the Prevention and Treatment of Chemotherapy-Induced Oral Mucositis.

Authors:  Mohammad Mahdi Kooshyar; Pegah Mosannen Mozafari; Maryam Amirchaghmaghi; Atessa Pakfetrat; Parisa Karoos; Mahdokht Rashed Mohasel; Hosein Orafai; Amir Abbas Azarian
Journal:  J Clin Diagn Res       Date:  2017-03-01

8.  Severe gastrointestinal mucositis following high dose melphalan therapy for multiple myeloma.

Authors:  Sanjeev Kumar Sharma; Anil Handoo; Dharma Choudhary; Gaurav Dhamija; Nitin Gupta
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

9.  Targeted inhibition of IL-18 attenuates irinotecan-induced intestinal mucositis in mice.

Authors:  R C P Lima-Júnior; H C Freitas; D V T Wong; C W S Wanderley; L G Nunes; L L Leite; S P Miranda; M H L P Souza; G A C Brito; P J C Magalhães; M M Teixeira; F Q Cunha; R A Ribeiro
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

10.  The effect of a supersaturated calcium phosphate mouth rinse on the development of oral mucositis in head and neck cancer patients treated with (chemo)radiation: a single-center, randomized, prospective study of a calcium phosphate mouth rinse + standard of care versus standard of care.

Authors:  Maarten Lambrecht; Carole Mercier; Yasmyne Geussens; Sandra Nuyts
Journal:  Support Care Cancer       Date:  2013-05-18       Impact factor: 3.603
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.